연구동향 분석
박사

증폭시킨 홍삼으로부터 분리한 Ginsenoside Rh2와 Compound K의 항염 및 항암효과 = Anti-inflammatory and Anti-cancer Effects of Ginsenoside Rh2, Compound K Isolated From Amplified Red Ginseng

김영호 2018년

논문상세정보
인용/피인용
' 증폭시킨 홍삼으로부터 분리한 Ginsenoside Rh2와 Compound K의 항염 및 항암효과 = Anti-inflammatory and Anti-cancer Effects of Ginsenoside Rh2, Compound K Isolated From Amplified Red Ginseng' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Ginsenoside Rh2
  • Red ginseng
  • compoundk
  • 항암
  • 항염
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
225 0

0.0%

' 증폭시킨 홍삼으로부터 분리한 Ginsenoside Rh2와 Compound K의 항염 및 항암효과 = Anti-inflammatory and Anti-cancer Effects of Ginsenoside Rh2, Compound K Isolated From Amplified Red Ginseng' 의 참고문헌

  • 홍삼과 하엽의 항염증 및 면역조절에 대한 연구
    윤재웅 가천대학교 대학 원 석사학위논문 [2013]
  • 홍삼과 백삼의 비교 고찰
    남기열 高麗人參學會誌, 29(1): 1-18 [2005]
  • 장지은, 차정단. 홍삼에탄올추출물의 염증유발인자에 대한 억제효과
    고은실 문정혜 박종혁 이민정 임지예 최경민 황승미 한국미생물 생명공 학회지, 43(2): 158-163 [2015]
  • 인삼 유래 성분들의 항염증 약리 효능
    김주영 조계열 고려인삼연구와 산업, 1(2): 17-23 [2007]
  • 백삼과 홍삼의 암세포에 대한 세포독성 및 세포 주기에 미치는 영향
    송선옥 정노팔 최상운 Journal of ginseng research, 24(4): 183-187 [2000]
  • 백삼, 홍삼, 발효인삼 농축액의 이화학적특성 및 약리효능에 관한 연구
    공병만 경희대학교 박사학위논문 [2008]
  • 박사
    마우스 대식세포 및 염증성 대장염 모델에서 홍삼의 항염효과에 관한 연구
    현미선 원광대학교 한의학전문대학원 박사학위논문 [2009]
  • 고려홍삼 성분이 암독소 호르몬-L의 체지방 분해작용에 미치는 영향
    이성동 황우익 한국식품영양학회지, 8(2): 105-109 [1995]
  • 고려인삼의 주요 효능과 그 임상적 응용
    남기열 高麗人參學會誌, 26(3): 111-131 [2002]
  • 건강기능식품의 시장현황 및 인삼시장의 전망
    도재호 이종원 高麗人參 學會誌, 29( 4): 206-214 [2005]
  • 건강기능식품에서 인삼/홍삼제품 시장 현황
    곽이성 김석창 도재호 박채규 황미선 고려인삼연구와 산업, 1(2): 9-16 [2007]
  • Yu CL, Jove R, Burakoff SJ. J Immunol. 1997. Constitutive activation of the J anus kinase-STAT pathway in T lymphoma overexpressing the Lck pr otein tyrosine kinase. Dec 1;159(11): 5206-5210.
  • Yoon SR, Lee GD and Kwon JH. 2010. Monitoring of roasting-induced c hanges in ginsenoside composition of ginseng (Panax ginseng C.A. Meyer). Food Sci. Biotechnol. 19: 151-157.
  • Yang WZ, Hu Y, Wu WY, Ye M and Guo DA. 2014. Saponins in the genus Pa nax L. (Araliaceae): A systematic review of their chemical diversity. Phytochemistry 106: 7-24.
  • Xie YY, Luo D, Cheng YJ, Ma JF, Wang YM, Liang QL and Luo GA. 2 012. Steaming-induced chemical transformations and holistic quality ass essment of red ginseng derived from Panax ginseng by means of HP LCESI-MS/MS(n)-based multicomponent quantification fingerprint J. Agr ic. Food Chem. 60: 8213-8224.
  • Wee JJ, Shin JY, Sohn HJ, Heo JN, KIm SK, Kim MW. 1997. Korean J. G inseng Sci. 21(3): 209-213.
  • Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. 2007. In vit ro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng.Cancer Chemotherapy and Pharmacology. 59(5): 589–601.
  • Wan JY, Fan Y, Yu QT, Ge YZ, Yan CP, Alolga RN, Li P, Ma ZH and Qi LW. 2015. Integrated evaluation of malonyl ginsenosides, amino ac ids and polysaccharides in fresh and processed ginseng. J. Pharm. Biom ed. Anal. 107: 89-97.
  • Trinh HT, Shin YW, Han SJ, Han MJ and Kim DH. 2008. Evaluation of a ntipruritic effects of red ginseng and its ingredients in mice. Plan ta Med.74: 210-214.
  • Tanaka O, Nagai M and Shibata S. 1996. Chemical studies on the oriental plant drugs. XVI. The stereochemistry of protopanaxadiol, a genui ne sapogenin of ginseng. Chem. Pharm. Bull. 14: 1150.
  • Taga T, Kawanishi Y, Hardy RR, Hirano T, Kishimoto T. 1987. Receptors for B cell stimulatory factor 2. Quantitation, specificity, distributi on, and regulation of their expression. J Exp Med. Oct 1;166(4): 967-981.
  • Suzuki Y, Ko SR, Choi KJ, Uchida K, Lee YG, Kim YH. 1998. Enzymatic g lycosylation and hydrolysis of ginseng saponins. Proceedings of I nternational Ginseng Symposium 7: 373-374.
  • Sung H. 2009. Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus ty pe 1-infected patients, Clin. Vaccine Immunol. 16(8): 1127-1131.
  • Simpson CD, Anyiwe K, Schimmer AD. 2008. Anoikis resistance and tumor m etastasis. Cancer Lett, 272(2): 177-185.
  • Shin JY, Song JY, Yun YS, Yang HO, Rhee DK, Pyo S. 2002. Immunostim ulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol. Immunotoxicol. 24: 46 9-482.
  • Shin JS, Kim JM, An WG. 2012. Anti-inflammatory Effect of Red Ginseng through Regulation of MAPK in Lipopolysaccharide-stimulated RAW 264.7, Journal of physiology & pathology in Korean Medicine. 26 (3): 293-300.
  • Shibata S, Tanaka P, Ando T, Sado M, Thushima S and Ohsawa T. 1966. Chemical studies on oriental plant drugs. XIV. Protopanaxadiol, a genuine sapogenin of ginseng saponins. Chem. Pharm. Bull. 14: 59 5-600.
  • Shibata S, Tanaka O, Shoji J, Saito H. 1995. Chemistry and pharmacology of Panax. In: Wagner H, Hikino H, Farnsworth NR, eds. Economic and Medicinal Plant Research. New York: Acedamic Press. 217-284.
  • Shibata S, Tanaka O, Nagai M. and Ishii T. 1963. Studies on the constitue nts of Japanese and Chinese crude drugs. XII. Panaxadiol, a sapo genin of ginseng roots. Chem. Pharm. Bull. 11: 762.
  • Senthil K, Veena V, Mahalakshmi M, Pulla R, Yang DC, Parvatham. 2009. Mi crobial conversion of major ginsenoside Rb1 to minor ginsenoside R d by Indian fermented food bacteria. African Journal of Biotechnolo gy 8: 6961-6966.
  • Sanata S, Kondo N, Shoji J, Tanaka O and Shibata S. 1974. Studies on the saponins of ginseng. I. Structure of ginseng-R0, Rb1, Rb2, Rc and Rd. Chem. Pharm. Bull. 22: 421.
  • Ronald LP, Guohua C. 1999. In vivo total antioxidant capacity comparison of different analytical method. Free Radic. Biol. Med. 27: 1173-1181.
  • Roitt I, Brostoff J, Male D. 1993. Immunology. 3rded. Mosby, New York.
  • Roberta R. 1999. Antioxidant activity applying an improved ABTSradical cat ion decolorization assay. Free Radical Biol Med 26: 1231-1237.
  • Reddig PJ, Juliano RL, 2005. Clinging to life: cell to matrix adhesion and cel l survival. Cancer Metastasis Rev, 24(3): 425-439.
  • Ramesh T, Kim SW, Sung JH, Hwang SY, Sohn SH, Yoo SK, Kim SK. 2012. Effect of fermented Panax ginseng extract (GINST) on oxidative st ress and antioxidant activities in major organs of aged rats. Experi mental Gerontology 47: 77-84.
  • RAW 264.7 세포에서 LPS 에 의해 유도된 염증에 대한 백삼, 홍삼, 발효홍삼의 항염효과에 대한 비교 연구
    문연자 손봉준 신용서 우원홍 허정무 현미선 Journal of applied biological chemistry, 52(1): 21-27 [2009]
  • Qi LW, Wang CZ and Yuna CS. 2011. Isolation and analysis of ginseng: adva nces and challenges. Nat. Prod. Rep. 28: 467-495.
  • Playfair JHL. 1992. Natural and adaptive immune mechanisms. In Immunolog y at a Glance. 5th edition. London: Blackwell Scientific Publications.
  • Park SJ, Kim DH. Paek NS, Kim SS. 2006. Preparation and quality characteristics of the fermentation product of ginseng by lactic acid bacteria (FGL). J Ginseng Res. 30: 88-94.
  • Park MG. 1994. Korean ginseng. Korea Ginseng and Tobacoo Research instit ute, Seoul Korea: 63.
  • Park JS. Cho JY, 2009. Anti-inflammatory effects of ginsenosides from P anax ginseng and their structural analogs, African journal of biote chnology. 8(16): 3682-3690.
  • Park JD. 1996. Recent Studies on the Chemical Constituents of Korean G inseng(panax ginseng C. A. Meyer). Korean J. Ginseng Sci 20: 389 -415.
  • Park HJ, Jung DH, Joo HM, Kang NS, Jang SA, Lee JG, and Sohn EH. 2010. The comparative study of anti-allergic and anti-inflammatory effects b y fermented red ginseng and red ginseng, Korean journal of plant resources. 23(5): 415-422.
  • Park CG, Jeon BS, Yang JW. 2003. The Chemical Components of Korean Ginseng. Food industry and Nutr. 8: 10-23.
  • Oh SH, Choi SY, Lee NR, Lee JN, Kim DS, Lee SH, and Park SM. 2014. Cell migration and Anti-inflammatory Effect of Red Ginseng Extracts Fe rmented with Laetiporus Sulphureus, Journal of the society of cosm etic scientists of Korea. 40(3): 297-305.
  • Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND. 19 99. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells, International journal of oncology. 14(5): 869-8 75.
  • Odashima S, Ohta T, Kohno H, Matsuda T, Kitagawa I, Abe H, Arichi S. 1985. Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Res 45: 2781-2784.
  • Niu G, Heller R, Catlett-Falcone R, Coppola D, Jaroszeski M, Dalton W, Jov e R, Yu H. 1999. Gene therapy with dominant-negative Stat3 supp resses growth of the murine melanoma B16 tumor in vivo. Cancer Res. Oct 15;59(20): 5059-5063.
  • Nelson CM, Bissell MJ, 2006. Of extracellular matrix, scaffolds, and signalin g: tissue architecture regulates development, homeostasis, and canc er. Annu Rev Cell Dev Biol, 22: 287-309.
  • Nam KY. 2005. The comparative understanding between red ginseng and white gin sengs, processed ginsengs(panax ginseng C. A. Meyer), J. Ginseng Re s. 29(1): 1-18.
  • Nam KY, Lee NR, Moon BD, Song GY, Shin HS and Choi JE. 2012. Chang es of ginsenosides and color from black ginsengs prepared by ste aming-drying cycles. Korean J. Medicinal Crop. Sci. 20: 2735.
  • Nam KY, Choi JE and Park JD. 2013. Transformation techniques for the lar ge scale production of ginsenoside Rg3. Korean J. Medicinal Crop. Sci. 2195: 401-414.
  • Moody GA, Jayanthi V, Probert CS, Mac Kay H, Mayberry JF. 1996. Longterm therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer ri sk and compliance with treatment in Leicestershire. Eur J Gastro enterol Hepatol 8: 1179-1183.
  • Ministry of Health and Welfare. 2006. Report on 2005 National Health and Nutrition survey. Seoul.
  • Mantovani, A., Allavena, P., Sica, A., Balkwill, F. (2008). Cancer-relatedinflammation.Nature454,436-444.
  • Man S, Gao, W, Zhang Y, Huang L and Liu C. 2010. Chemical study and me dical application of saponins as anticancer agents. Fitoterapia 81: 7 03-714.
  • Lindmark E, Diderholm E, Wallentin L, Siegbahn A. 2001. Relationship betwe en interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strateg y. JAMA. Nov 7;286(17): 2107-2113.
  • Lim TS, Na K, Choi EM, Chung JY, Hwang JK. 2004. Immunomodulating act ivities of polysaccharides isolated from Panax ginseng. J. Med. Foo d 7: 1-6.
  • Levy DE, Darnell JE Jr. 2002. Stats: transcriptional control and biological im pact. Nat Rev Mol Cell Biol. Sep;3(9): 651-662. Review.
  • Lee SR, Park JH, Choi KJ, Kim ND. 1997. Korean J. Ginsneg Sci. 21(2): 13 2-140.
  • Lee MR, Kim BC, Kim R, Oh HI, Kim HK, Choi KJ, Sung CK. 2013. Anti-o besity effects of black ginseng extract in high fat diet-fed mice. J ournal of ginseng research. 37(3): 308-314.
  • Lee JR, Kim YW, Byun SH, Kim SC, Park SJ. 2015. Anti-inflammatory effects of the fermentation extracts consisting of soybean, red gi nseng and Citrus Unshiu Peel, The Korea journal of herbology. 30 (5): 59-65.
  • Lee HS, Lee HJ, Yu HJ, Ju do W, Kim Y, Kim CT, Kim CJ, Cho YJ, Kim N, Choi SY and Suh HJ A. 2011. Comparison between high hydrostatic pressure extraction and heat extraction of ginsenosides fro m ginseng (Panax ginseng CA Meyer). J. Sci. Food Agric. 91: 146 6-1473.
  • Korea National Statistical Office. 2005. Annual report of mortality statistics. Se oul.
  • Kong BM, Park MJ, Min JW, Kim HB, Kim SH, Kim SY. Yang DC. 2008. Physicochemical characteristics of white, fermented and red ginseng extracts. J Ginseng Res. 32: 238-243.
  • Kitagawa I, Taniyama T, Shibuya H, Nota T and Yoshikawa M. 1987. Chemi cal studies on crude drug processing. V. On the constituents of gin seng radix rubra (2) ; Comparison of the constituents of White gin seng and Red ginseng prepared from the same Panax ginseng root. Yakugaku Zasshi. 107: 495-505.
  • Kim YS, Kim DS, Kim SI. 1998. Ginsenoside Rh2 and Rh3 induce differentiation o f HL-60 cells into granulocytes: modulatin of protein kinase C is oforms during differentiation by ginsenoside Rh2. Int J Biochem Cell B iol 30: 327-338.
  • Kim YN, Koo KH, Sung JY, Yun UJ, Kim HR. 2012. Anoikis resistance: an e ssential prerequisite for tumor metastasis. Int J Cell Biol. 306-879.
  • Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK and Park J H. 2000. Steaming of ginseng at high temperature enhances bio logical activity. Nat. Prod. 63: 1702-1704.
  • Kim MH, Hong HD, Kim YC, Rhee YK, Kim KT and Rho JH. 2010. Ginseno side changes in red ginseng manufactured by acid impregnation trea tment. J. Ginseng Res. 34: 93-97.
  • Kim JH, Cho SY, Kang CW, Yoon IS, Lee JH, Jeong SM, Lee BH, Lee JH, Pyo MK, Choi SH, Quan SF, Lee JH, Choi CB, Rhim H, Nah SY. 2006. Ginseng saponins diminish adverse vascular effects associated with chronic methionine-induced hyperhomocysteinmia. Biol. Pharm. Bull. 29: 2425-2431.
  • Kim HJ, Lee JY, You BR, Kim HR, Choi JE, Nam KY, Moon BD and Kim M R. 2011. Antioxidant activities of ethanol extracts from black ginse ng prepared by steamingdrying cycles. J. Korean Soc. Food Sci. Nu tr. 40: 156-162.
  • Kim HJ, Kim MH, Byon YY, Park JW, Jee Y, Joo HG. 2007. Radioprotective effects of an acidic polysaccharide of Panax ginseng on bone marro w cells. J. Vet. Sci. 8: 39-44.
  • Kim HG, Kim KY, Cha CJ. 2007. Screening for ginseng-fermenting microorg anisms capable of biotransforming ginsenosides. Korean J Microbiol 43: 142-146.
  • Kim EJ, Jung IH, Van Le TK, Jeong JJ, Kim NJ and Kim DH. 2013. Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in m ice. J. Ethnopharmacol. 146: 294-299.
  • Kim DW, Lee YJ, Min JW, Lee BS, In HG and Yang DC. 2008. Conversion of brown materials, crude Lipids, crude proteins and aromatic co mpounds of changed ginseng by 9 repetitive steaming and drying process. Korean J. Oriental Physiology & Pathology 22: 333-339.
  • Kim BW, Lee YB, Park JS, Park JW, Hwang SY. 2013. The Effect of Red Ginseng Extracts on Blood Biochemical Parameters, Bone Density an d Bone Inorganic Components in Ovariectomized Rats, The Journ al of digital policy & management. 11(10): 493-505.
  • Kim BW, Lee YB, Park JS, Park JW, Hwang SY. 2013. Effect of Red Ginseng S aponin Fraction on the Blood Components of Male Guinea Pigs wit h Acute Toxicity induced by 2,3,7,8-Tetracholorodibenzo-ρ-diox in (TCDD), The Journal of digital policy & management. 11(4): 3 39-350.
  • Kim AJ, Kang S J, Lee KH, Lee MS, Ha SD, Cha YS and Kim SY. 2010. T he chemopreventive potential and antiinflammatory activities of Kor ean black ginseng in colon 26- M3.1 carcinoma cells and macropha ges. J. Kor. Soc. Appl. Biol. Chem. 53: 101-105.
  • Kim AJ, Han, Lee SJ. 2012. Antioxidative Capacity and Quality Characteristics of Yanggaeng using Fermented Red Ginseng for the Elderly, The Kore an journal of food and nutrition. 25(1): 83-89.
  • Kang KS, Woo JH and Kim AJ. 2013. The effects of Korean ginseng on m emory loss in a rat models. J. Korean Soc. Food Sci. Nutr. 42: 11 90-1196.
  • Kang H, Hwang YG, Lee TG, Jin CR, Cho CH, Jeong HY, Kim DO. 2016. Use of Gold Nanoparticle Fertilizer Enhances the Ginsenoside Con tents and Anti-Inflammatory Effects of Red Ginseng, Journal of mi crobiology and biotechnology. 26(10): 1668-1674.
  • Jung S, Lee MS, Shin Y, Kim CT, Kim IH, Kim YS, Kim Y. 2014. Anti-obesity and anti-inflammatory effects of high hydrostatic pressure extracts of ginseng in high-fat diet induced obese rats, Journal of functional food s : the official journal of the International Society for Nutra ceuticals & Functional Foods. 10: 169-177.
  • Jung HJ, Choi HJ, Lim HW, Shin DH, Kim HS, Kwon B, Lee JE, Park EH, Lim CJ. 2012. Enhancement of anti-inflammatory and antinociceptive ac tions of red ginseng extract by fermentation, Journal of pharmacy and pharmacology. 64(5): 756-762.
  • Jin Y, Kim YJ, Jeon JN, Wang Chao, Min JW, Jung SY and Yang DC. 2012. Changes of ginsenosides and physiochemical properties in ginseng by new 9 repetitive steaming and drying process. Korean J. Plant Res. 25: 473-481.
  • Jin BM, Lee MK, Lee JS, Hyun KY. 2014. Anti-inflammatory Effects of Korean red ginseng Extract in formalin-induced Orofacial Pain in Rats, Jo urnal of the Korea Academia-Industrial cooperation Society. 15 (9): 5708-5715.
  • Jang DJ. 2008. Red ginseng for treating erectile dysfunction: a systematic re view, Br. J. Clin. Pharmacol. 66(4): 444-450.
  • Jang AY, Sueng YC, Ji JG. 2016. The comparative study on physiological act ivity of White ginseng, Red ginseng and Black ginseng extract. Jour nal of Digital Convergence. 14(5): 459-471.
  • Ishihara K, Hirano T. 2002. IL-6 in autoimmune disease and chronic inflam matory proliferative disease. Cytokine Growth Factor Rev. Aug-Oc t;13(4-5): 357-68.
  • Huang KC. 1999. The Pharmacology of Chinese Herbs. Boca Raton, FL: CRC Press.
  • Huang KC. 1998. A brief history of Chinese medicine. In The Pharmacology of Chinese Herbs. CRC Press, Florida, USA. 11-23.
  • Hossen MJ, Hong YD, Baek KS, Yoo S, Hong YH, Kim JH, Lee JO, Kim D H , Park JS, Cho JY. 2017. In vitro antioxidative and anti-inflammatory ef fects of the compound K-rich fraction BIOGF1K, prepared from Pa nax ginseng, Journal of ginseng research. 41(1): 43-51.
  • Hong CE, Lyu SY. 2011. Anti-inflammatory and Anti-oxidative Effects of Korean Red Ginseng Extract in Human Keratinocytes, Immune network : of ficial journal of the Korean association of immunobiologists. 11(1) : 42-49.
  • Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiw amura S, Nakajima K, Koyama K, Iwamatsu A, et al. 1986. Comple mentary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. Nov 6-12;324(6 092): 73-76.
  • Ha Jh. 2010. Enhancement of Biological Activities of Low Quality Fresh Ginseng by Various Extraction Processes 1: 25-27.
  • Gwag IS, Park JD, Yang JW. 2003. Present and It's prospect of Red Ginseng Efficacy Research. Food industry and Nutr. 8: 30-37.
  • Gouilleux-Gruart V, Debierre-Grockiego F, Gouilleux F, Capiod JC, Claisse J F, Delobel J, Prin L. 1997. Activated Stat related transcription factors in acute leukemia. Leuk Lymphoma. Dec;28(1-2): 83-88.
  • Giustarini D, Dalle-Donne I, Tsikas D and Rossi R, 2009. Oxidative stress a nd human diseases: origin, link, measurement, mechanisms, and biom arkers. Crit. Rev. Clin. Lab. Sci. 46: 241-281.
  • Garriques, S.S. 1854. Ann. Chem. Pharm. 90: 234.
  • Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, Travis WD, Bornmann W, Veach D, Clarkson B, Bromberg JF. 2007. Mutations in the EGFR kina se domain mediate STAT3 activation via IL-6 production in hu man lung adenocarcinomas. J Clin Invest. Dec;117(12): 3846-3856.
  • Frisch SM, Screaton RA. 2001. Anoikis mechanisms, Current Opinion in Cell Biology. 13(5): 555-562, http://dx.doi.org/10.1016/S0955-0674(00)00251-9. PMID 11544023.
  • Frisch SM and Francis H. 1994. Disruption of epithelial cell-matrix interactions in duces apoptosis. Journal of Cell Biology. 124(4): 619–626.
  • Frank DA, Mahajan S, Ritz J. 1997. B lymphocytes from patients with chronic ly mphocytic leukemia contain signal transducer and activator of tran scription (STAT) 1 and STAT3 constitutively phosphorylated on serin e residues. J Clin Invest. Dec 15;100(12): 3140-3148.
  • Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. 2000. Colorectal cancer pr evention in ulcerative colitis: a case-control study. Aliment Pha rmacol Ther 14: 145-153.
  • Dong H, Bai LP, Wong VK, Zhou H, Wang JR, Liu Y, Jiang ZH and Liu L. 2 011. The in vitro structurerelated anti-cancer activity of gi nsenosides and their derivatives. Molecules 16: 10619-10630.
  • Dejian H, Ou B, Prior DL. 2005. The chemistry behind antioxidant capacity assays. J Agric Food Chem 53: 1841-1856.
  • Darnell JE Jr. 1997. STATs and gene regulation. Science. Sep 12;277(533 2): 1630-1635. Review.
  • Culter RG. 1984, Antioxidants aging and longevity. In Free Radicals in Biology. P ryor WA, ed. Academic Press, New York, USA. 6: 371-423.
  • Chu S, Gu J, Feng L, Liu J, Zhang M, Jia X, Liu M and Yao D. 2014. Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-in duced memory impaired rats via attenuating neuroinflammatory respon ses. Int. Immunopharmacol. 19: 317-326.
  • Christensen LP. 2008. Ginsenosides: Chemistry, Biosynthesis, Analysis, and Po tential Health Effects. Advances in Food and Nutrition Research. 55: 1-99.
  • Choi, K. T. 2008. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C. A. Meyer. Acta. Pharmacol. Sin. 29: 1109-1118.
  • Choi Y.M., Kim M.H., Shin J.J., Park J.M. and Lee J.S. 2003. The antioxidant activities of the some commercial teas. J Korean Soc Food Sci Nutr. 32: 723-727.
  • Choi JE, Li X, Han YH, Lee KT. 2009. Changes of saponin contents of leave s, stems and flower-buds of Panax ginseng C. A. Meyer by harves ting days. Korean J Med Crop Sci 17: 251-256.
  • Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. 2006. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 550: 173-179.
  • Cho JY. 2002. Ginsenosides from Panax ginseng differentially regulate l ymphocyte proliferation. Planta Med. 68(6): 497-500.
  • Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fern ndez-Luna JL, Nu ez G, Dalton WS, Jove R. 1999. Constitutive activation of Stat3 signaling confers resista nce to apoptosis in human U266 myeloma cells. Immunity. Jan;10 (1): 105-115.
  • Bingle L, Brown NJ, Lewis CE. 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer ther apies. J Pathol 196: 254-265.
  • Benzie, I. F., Strain, J. J. 1996. The ferric reducing ability of plasma (FRAP) as a measure of “Antioxidant Power”: The FRAP assay. Anal Biochem. 239: 70-76.
  • Bao HY, Zhang J, Yeo SJ, Myung CS, Kim HM, Kim JM, Park JH, Cho J and Kang JS. 2005. Memory enhancing and neuroprotective effects of selected g insenosides. Arch. Pharm. Res. 28: 335-342.
  • Balkwil,l.F.,Mantovani,A.(2001).Inflammationandcancer:backto Virchow?Lancet357,539–545.
  • Bae EA. 2005. antiallergic and antipsoriatic effects of korean red ginseng, J. Ginseng Res. 29(2): 80-85.
  • Bae EA, Joo HM, Shin YW and Kim DH. 2006. Inhibitory effects of korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cultaneous anaphylaxis reaction and contact dermatit is models. Biol. Pharm. Bull. 29: 1862-1867.
  • Attele AS,Wu JA,Yuan CS (1999)Ginseng pharmacology:multiple constituents and multiple actions. Biochem Pharmacol. 58, 1685-1693.
  • Ancrile B, Lim KH, Counter CM. 2007. Oncogenic Ras-induced secretion o f IL6 is required for tumorigenesis. Genes Dev. Jul 15;21(14): 171 4-1719.
  • An YE, Ahn SC, Yang DC, Park SJ, Kim BY and Baik MY. 2011. Chemical conversion o f ginsenosides in puffed red ginseng. LWT – Food Sci. Technol. 44: 370-374.
  • Akira S, Taga T, Kishimoto T. 1993. Interleukin-6 in biology and medicine. Adv Immunol. ;54:1-78. Review. No abstract available.